Currently out of the existing stock ratings of Lisa Walter, 46 are a BUY (88.46%), 6 are a HOLD (11.54%).
Analyst Lisa Walter, currently employed at RBC, has had 22.26% of price targets met with an average potential upside of 24.36%, reached in 67 days on average.
Lisa Walter has documented 103 price targets and ratings displayed on 10 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on UTHR, United Therapeutics at 05-Nov-2026.
Analyst best performing recommendations are on APLS (APELLIS PHARMACEUTICALS).
The best stock recommendation documented was for EYPT (EYEPOINT PHARMACEUTICALS) on 8/18/2026. The price target of $5 was fulfilled within 6 days with a profit of $0.47 (8.59%), with a performance score of 14.32.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Apr-2024
$5
1 years 1 days ago
(17-Nov-2025)
0/6 (0%)
$0.73 (17.10%)
Buy Since 28-Apr-2020
$5.5
$12
1 years 20 days ago
(29-Oct-2025)
1/8 (12.5%)
$1.27 (30.02%)
366
Hold Since 16-Apr-2025
$4
$5
1 years 21 days ago
(28-Oct-2025)
1/2 (50%)
$-0.26 (-6.10%)
168
Buy Since 18-Jul-2024
1 years 3 months 5 days ago
(13-Aug-2025)
0/2 (0%)
$30.52 (321.94%)
Hold Since 11-Nov-2022
$4
$5
1 years 6 months 3 days ago
(15-May-2025)
4/9 (44.44%)
$1.95 (95.12%)
102
Which stock is Lisa Walter most bullish on?
Which stock is Lisa Walter most reserved on?
What Year was the first public recommendation made by Lisa Walter?